After skin Cancer, prostate cancer is most common cancer among men in the United States and the third leading cause of cancer death. MAOA enzyme helps prostate cancer cells spread to boneThe researchers came to their findings by introducing human prostate cancer cell lines into mice and analyzing MAOA activity. Researchers suggest that antidepressants that block the enzyme MAOA could reduce the spread of prostate cancer cells to the bone. According to the American Cancer Society, there will be 161,360 new cases of prostate cancer diagnosed in 2017, and more than 26,000 men will die from the disease. When prostate cancer cells spread to other body parts - a process known as metastasis - the bone is the normally the first area affected.
Like many cancers, prostate cancer rarely stays put in the organ it is named for. … current therapies have very limited or no effectiveness for prostate cancer patients who develop metastatic bone tumors. Even more notably, "current therapies have very limited or no effectiveness for prostate cancer patients who develop metastatic bone tumors," he said. The disease has a special knack for spreading into bones, a painful and lethal development that affects 90 percent of patients who die of prostate cancer. In his study, Wu also found that a drug similar to ones used in antidepressants was able to disrupt the MAOA enzyme, meaning it could be used to prevent prostate cancer from spreading to the bones.
collected by :Lucy William
No comments:
Post a Comment